The question
Does FDA review a compounded drug in the same way it reviews an approved drug?
The short answer
No. FDA states that compounded drugs are not FDA-approved. The agency does not review their safety, effectiveness, or quality before they are marketed.
Compounding can help a patient whose needs cannot be met by an available approved medicine. For example, a person may need a formula without an ingredient that causes an allergy. Someone who cannot swallow a pill may need a liquid form instead.
What to ask
If a compounded product is being considered, ask the licensed professionals responsible for your care:
- What need cannot be met by an available approved product?
- Who prescribed and compounded the drug?
- What quality rules and tests apply?
- What does the label say?
- How will benefits and harmful effects be watched?
- Which approved options were considered?
- How should a problem or harmful event be reported?
Marketing language to check
Slow down if a page does any of the following:
- Calls a compounded product FDA-approved
- Suggests that compounding proves safety or effectiveness
- Calls a compounded drug identical to an approved finished product without support
- Leaves out important limits while making strong health claims
Practical takeaway
Use “compounded” as a product category. Do not treat the word as proof of approval, safety, effectiveness, or quality.
Sources
These links go to the official pages used for this brief. Source pages and official positions can change, so check them again before relying on a detail.
Educational information only
This brief does not provide medical advice or recommend a product, treatment, dose, source, or protocol. Use it to prepare questions for a licensed professional who knows your history.
To report an error, email hello@peptideliteracylab.com. Include the brief title, the statement, and a supporting source.